Alkermes plc
ALKS$42.97+3.64% 1D
$27.0052-week range$55.67
Updated . Prices are snapshots and may be delayed.
Alkermes plc price chart
+6.97% over 7D
$43.23
$39.09
Oct 18
Oct 20
AI Outlook for Alkermes plc
Neutral posture- Long-term trend+8.0% vs 200-day average
- Medium-term trend-4.4% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Alkermes plc performance
1D
+3.6%
7D
+6.7%
30D
−1.0%
90D
−18.7%
1Y
+44.2%
About Alkermes plc
Alkermes plc is a biotechnology company based in Ireland, listed on NASDAQ since 1991 (ticker ALKS).
The shares trade at a price-to-earnings ratio of 110.1.
Alkermes plc market data
What is the price of Alkermes plc today?
Alkermes plc (ALKS) is at $42.97, +3.64% on the day.
What is the 52-week range of Alkermes plc?
Over the past year Alkermes plc has traded between $27.00 and $55.67. It is currently 56% of the way up that range.
What is the P/E ratio of Alkermes plc?
Alkermes plc trades at a price-to-earnings ratio of 110.1.
Similar stocks
MRNA
Moderna Inc
$226.89+4.4%
IBRX
Immunitybio Inc
$8.42−8.4%
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
$3.61+2.3%
TCRT
Alaunos Therapeutics, Inc. Common Stock
$3.13+5.0%
BCRX
BioCryst Pharmaceuticals, Inc.
$8.07+3.9%
IOVA
Iovance Biotherapeutics, Inc.
$14.21+3.0%
PDSB
PDS Biotechnology Corporation
$0.9165−18.9%
AKBA
Akebia Therapeutics, Inc.
$0.6801+0.9%
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.